UBS Group AG - ENVERIC BIOSCIENCES INC ownership

ENVERIC BIOSCIENCES INC's ticker is and the CUSIP is 29405E208. A total of 13 filers reported holding ENVERIC BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ENVERIC BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$740
+306.6%
311
+475.9%
0.00%
Q2 2023$182
-97.9%
54
-99.0%
0.00%
Q1 2023$8,850
+76.8%
5,318
+121.0%
0.00%
Q4 2022$5,005
-77.2%
2,406
-53.7%
0.00%
Q3 2022$22,0005,2020.00%
Other shareholders
ENVERIC BIOSCIENCES INC shareholders Q3 2022
NameSharesValueWeighting ↓
AdvisorShares Investments LLC 100,429$338,4460.10%
Tower Research Capital LLC (TRC) 8,327$28,0620.00%
UBS Group AG 54$1820.00%
BANK OF AMERICA CORP /DE/ 101$3400.00%
WELLS FARGO & COMPANY/MN 30$1010.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GROUP ONE TRADING, L.P. 273$9200.00%
MORGAN STANLEY 1$30.00%
ACADIAN ASSET MANAGEMENT LLC 4,559$150.00%
NATIONAL BANK OF CANADA /FI/ 70$2320.00%
View complete list of ENVERIC BIOSCIENCES INC shareholders